N-[3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynyl]acetamide;N-[3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynyl]methanesulfonamide;3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynylurea;5-[3-(1,1-dioxo-1,4-thiazinan-4-yl)prop-1-ynyl]-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;molecular hydrogen

C68H99N25O6S2 — CID 160979830

IUPACN-[3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynyl]acetamide;N-[3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynyl]methanesulfonamide;3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynylurea;5-[3-(1,1-dioxo-1,4-thiazinan-4-yl)prop-1-ynyl]-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;molecular hydrogen
SMILESCC(=O)NCC#Cc1cnc(N)c(-c2nc3ccc(C)cc3[nH]2)n1.Cc1ccc2nc(-c3nc(C#CCN4CCS(=O)(=O)CC4)cnc3N)[nH]c2c1.Cc1ccc2nc(-c3nc(C#CCNC(N)=O)cnc3N)[nH]c2c1.Cc1ccc2nc(-c3nc(C#CCNS(C)(=O)=O)cnc3N)[nH]c2c1.[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H]
InChIInChI=1S/C19H20N6O2S.C17H16N6O.C16H15N7O.C16H16N6O2S.16H2/c1-13-4-5-15-16(11-13)24-19(23-15)17-18(20)21-12-14(22-17)3-2-6-25-7-9-28(26,27)10-8-25;1-10-5-6-13-14(8-10)23-17(22-13)15-16(18)20-9-12(21-15)4-3-7-19-11(2)24;1-9-4-5-11-12(7-9)23-15(22-11)13-14(17)20-8-10(21-13)3-2-6-19-16(18)24;1-10-5-6-12-13(8-10)22-16(21-12)14-15(17)18-9-11(20-14)4-3-7-19-25(2,23)24;;;;;;;;;;;;;;;;/h4-5,11-12H,6-10H2,1H3,(H2,20,21)(H,23,24);5-6,8-9H,7H2,1-2H3,(H2,18,20)(H,19,24)(H,22,23);4-5,7-8H,6H2,1H3,(H2,17,20)(H,22,23)(H3,18,19,24);5-6,8-9,19H,7H2,1-2H3,(H2,17,18)(H,21,22);16*1H
InChIKeySZJBWVCHILCDLH-UHFFFAOYSA-N
MW1426.84 g/mol
LogP8.07
Rot. Bonds9

About N-[3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynyl]acetamide;N-[3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynyl]methanesulfonamide;3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynylurea;5-[3-(1,1-dioxo-1,4-thiazinan-4-yl)prop-1-ynyl]-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;molecular hydrogen

N-[3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynyl]acetamide;N-[3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynyl]methanesulfonamide;3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynylurea;5-[3-(1,1-dioxo-1,4-thiazinan-4-yl)prop-1-ynyl]-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;molecular hydrogen (PubChem CID 160979830) has the molecular formula C68H99N25O6S2 and a molecular weight of 1426.84 g/mol. Its IUPAC name is N-[3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynyl]acetamide;N-[3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynyl]methanesulfonamide;3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynylurea;5-[3-(1,1-dioxo-1,4-thiazinan-4-yl)prop-1-ynyl]-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;molecular hydrogen.

Molecular Properties

Compound NameN-[3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynyl]acetamide;N-[3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynyl]methanesulfonamide;3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynylurea;5-[3-(1,1-dioxo-1,4-thiazinan-4-yl)prop-1-ynyl]-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;molecular hydrogen
PubChem CID160979830
Molecular FormulaC68H99N25O6S2
Molecular Weight1426.84 g/mol
Exact Mass1425.77
IUPAC NameN-[3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynyl]acetamide;N-[3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynyl]methanesulfonamide;3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynylurea;5-[3-(1,1-dioxo-1,4-thiazinan-4-yl)prop-1-ynyl]-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;molecular hydrogen
SMILESCC(=O)NCC#Cc1cnc(N)c(-c2nc3ccc(C)cc3[nH]2)n1.Cc1ccc2nc(-c3nc(C#CCN4CCS(=O)(=O)CC4)cnc3N)[nH]c2c1.Cc1ccc2nc(-c3nc(C#CCNC(N)=O)cnc3N)[nH]c2c1.Cc1ccc2nc(-c3nc(C#CCNS(C)(=O)=O)cnc3N)[nH]c2c1.[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H]
InChIInChI=1S/C19H20N6O2S.C17H16N6O.C16H15N7O.C16H16N6O2S.16H2/c1-13-4-5-15-16(11-13)24-19(23-15)17-18(20)21-12-14(22-17)3-2-6-25-7-9-28(26,27)10-8-25;1-10-5-6-13-14(8-10)23-17(22-13)15-16(18)20-9-12(21-15)4-3-7-19-11(2)24;1-9-4-5-11-12(7-9)23-15(22-11)13-14(17)20-8-10(21-13)3-2-6-19-16(18)24;1-10-5-6-12-13(8-10)22-16(21-12)14-15(17)18-9-11(20-14)4-3-7-19-25(2,23)24;;;;;;;;;;;;;;;;/h4-5,11-12H,6-10H2,1H3,(H2,20,21)(H,23,24);5-6,8-9H,7H2,1-2H3,(H2,18,20)(H,19,24)(H,22,23);4-5,7-8H,6H2,1H3,(H2,17,20)(H,22,23)(H3,18,19,24);5-6,8-9,19H,7H2,1-2H3,(H2,17,18)(H,21,22);16*1H
InChIKeySZJBWVCHILCDLH-UHFFFAOYSA-N
XLogP8.07
TPSA489.69 Ų
H-Bond Donors12
H-Bond Acceptors23
Rotatable Bonds9
Heavy Atoms101
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001426.84
LogP ≤ 58.07
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1023

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze N-[3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynyl]acetamide;N-[3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynyl]methanesulfonamide;3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynylurea;5-[3-(1,1-dioxo-1,4-thiazinan-4-yl)prop-1-ynyl]-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;molecular hydrogen with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynyl]acetamide;N-[3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynyl]methanesulfonamide;3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynylurea;5-[3-(1,1-dioxo-1,4-thiazinan-4-yl)prop-1-ynyl]-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;molecular hydrogen?
The IUPAC name of N-[3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynyl]acetamide;N-[3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynyl]methanesulfonamide;3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynylurea;5-[3-(1,1-dioxo-1,4-thiazinan-4-yl)prop-1-ynyl]-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;molecular hydrogen (CID 160979830) is N-[3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynyl]acetamide;N-[3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynyl]methanesulfonamide;3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynylurea;5-[3-(1,1-dioxo-1,4-thiazinan-4-yl)prop-1-ynyl]-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;molecular hydrogen.
What is the SMILES notation for N-[3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynyl]acetamide;N-[3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynyl]methanesulfonamide;3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynylurea;5-[3-(1,1-dioxo-1,4-thiazinan-4-yl)prop-1-ynyl]-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;molecular hydrogen?
The canonical SMILES for N-[3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynyl]acetamide;N-[3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynyl]methanesulfonamide;3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynylurea;5-[3-(1,1-dioxo-1,4-thiazinan-4-yl)prop-1-ynyl]-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;molecular hydrogen is CC(=O)NCC#Cc1cnc(N)c(-c2nc3ccc(C)cc3[nH]2)n1.Cc1ccc2nc(-c3nc(C#CCN4CCS(=O)(=O)CC4)cnc3N)[nH]c2c1.Cc1ccc2nc(-c3nc(C#CCNC(N)=O)cnc3N)[nH]c2c1.Cc1ccc2nc(-c3nc(C#CCNS(C)(=O)=O)cnc3N)[nH]c2c1.[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].
What is the InChIKey of N-[3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynyl]acetamide;N-[3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynyl]methanesulfonamide;3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynylurea;5-[3-(1,1-dioxo-1,4-thiazinan-4-yl)prop-1-ynyl]-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;molecular hydrogen?
The InChIKey is SZJBWVCHILCDLH-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H20N6O2S.C17H16N6O.C16H15N7O.C16H16N6O2S.16H2/c1-13-4-5-15-16(11-13)24-19(23-15)17-18(20)21-12-14(22-17)3-2-6-25-7-9-28(26,27)10-8-25;1-10-5-6-13-14(8-10)23-17(22-13)15-16(18)20-9-12(21-15)4-3-7-19-11(2)24;1-9-4-5-11-12(7-9)23-15(22-11)13-14(17)20-8-10(21-13)3-2-6-19-16(18)24;1-10-5-6-12-13(8-10)22-16(21-12)14-15(17)18-9-11(20-14)4-3-7-19-25(2,23)24;;;;;;;;;;;;;;;;/h4-5,11-12H,6-10H2,1H3,(H2,20,21)(H,23,24);5-6,8-9H,7H2,1-2H3,(H2,18,20)(H,19,24)(H,22,23);4-5,7-8H,6H2,1H3,(H2,17,20)(H,22,23)(H3,18,19,24);5-6,8-9,19H,7H2,1-2H3,(H2,17,18)(H,21,22);16*1H.
What are the key properties of N-[3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynyl]acetamide;N-[3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynyl]methanesulfonamide;3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynylurea;5-[3-(1,1-dioxo-1,4-thiazinan-4-yl)prop-1-ynyl]-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;molecular hydrogen?
N-[3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynyl]acetamide;N-[3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynyl]methanesulfonamide;3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynylurea;5-[3-(1,1-dioxo-1,4-thiazinan-4-yl)prop-1-ynyl]-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;molecular hydrogen has a molecular weight of 1426.84 g/mol, XLogP of 8.07, 9 rotatable bonds, 12 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynyl]acetamide;N-[3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynyl]methanesulfonamide;3-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]prop-2-ynylurea;5-[3-(1,1-dioxo-1,4-thiazinan-4-yl)prop-1-ynyl]-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;molecular hydrogen is sourced from PubChem (CID 160979830), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).